what's the difference between glp1 and tirzepatide vs Semaglutide: What You Need to Know GLP-1 Vs Tirzepatide: Powerful Guide

Yet for many people with hormonal or metabolic drivers of obesity, calorie restriction and activity alone produce slow or limited weight loss

Zepbound (tirzepatide) is a once-weekly subcutaneous GLP-1 receptor agonist and GIP receptor agonist indicated for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia

Many people report having no interest in food at all, which while effective for weight loss can lead to nutritional deficiencies if not managed properly

Journal of Clinical Medicine, 10(9), 1891

They can help you: Integrate movement: Guide you on adding the necessary strength training to your week to preserve muscle, along with cardio for heart health

What if I am not approved